Nasha Fitter is a leader in rare disease drug development and real-world evidence research. After her daughter’s diagnosis, she co-founded the FOXG1 Research Foundation, pioneering a faster, more cost-effective path to gene therapy clinical trials. She is also the Co-Founder and Chief Business Officer of Citizen Health, a patient-directed healthcare platform for rare and complex diseases. In addition, Nasha serves on the board of the Buffalo Initiative, helping unlock funding for nonprofits pursuing cures. She holds an MBA from Harvard Business School and is dedicated to accelerating treatments for rare diseases.